Mitigating out-of-pocket costs for insulin users

This report identifies potential approaches that plan administrators could take in an effort to reduce out-of-pocket costs for insulin-taking members. Key metrics resulting from this analysis include total member savings, reduction of insulin out-of-pocket costs, and increases in plan premiums.

This article was commissioned by Eli Lilly.